MSN initiates phase III trials of Molnupiravir
Hyderabad, 25 May (SocialNews.XYZ) MSN Laboratories Pvt. Ltd. (MSN) on Tuesday announced it is initiating phase III clinical trials of Molnupiravir capsules for the treatment of Covid-19 in India. MSN received clinical trial approval from…


















